Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by stockbuphoonon Jul 09, 2021 12:36pm
39 Views
Post# 33521598

RE:+5% ... reversing.....finally

RE:+5% ... reversing.....finally

Still no word on what they will do with a year of cash. Since Tommyjones will not look at real facts in q1, they have exhausted their $21M in cash from Mar 31st and are already using the $17M they received for the plasma collection centres. That will last 2 months. They have $5M for plasma division and another approx $70M for voucher. But, they only have preclinical trials to work on listed in q1 presentation. That's about a year of cash with financing costs.


Why is management silent on any 4050 development? No mention of heart, liver or kidney at all in last year... wonder why? What happened to 4547? Just kinda disappeared, right? They have spent over $500M over past 4 years and sold Ryplazim as a result for a voucher. Great management!!!


tommyjones1 wrote:

Or sell and listen to stockbufoon ever changing stories.

News soon on those production jobs + voucher money (all in, about 100M$).

 

good luck.
 



<< Previous
Bullboard Posts
Next >>